Overview
Trince develops precision transfection solutions for the biotechnology research sector. Transfection is a laboratory technique used to introduce nucleic acids into cells for research and development purposes.
Key people
In the news
- What makes a successful transfection? Our CEO Kevin Braeckmans explains the photoporation method and discusses the difference between successful delivery and the cells’ ability to process the delivered cargo effectively. Read all about it here: https://lnkd.in/e6WuRHPS
- It was with great pride that we presented our latest iPSC results at the Center for iPS Cell Research and Application (CiRA) during the celebration of the 20th anniversary of the discovery of iPSCs. The LumiPore proves to be a gentle and effective method for iPSC and iPSC-derived cell engineering. Thanks Lucia Pappagallo, PhD for the wonderful talk! Thanks to our partner Meiwafosis Inc. / メイワフォーシス株式会社 for making this possible.
- Working with iPSCs or iPSC-derived cells? The International Society for Stem Cell Research is hosting a special event taking place in Kyoto, home of the Center for iPS Cell Research and Application (CiRA), celebrating the 20th anniversary of iPSC discovery. Next Wednesday, October 21 at 4:15 PM local time, Lucia Pappagallo, PhD will present our latest data on using the LumiPore platform for efficient delivery into iPSCs and iPSC-derived cells. Don't forget to pass by booth #5 to meet Lucia Pappagallo, PhD, Jan Van Hauwermeiren
- We're off at ELRIG Drug Discovery 2026 in London! Visit us at booth #J20 to discover how Lumipore® is making intracellular delivery more accessible, combining a cell-friendly approach with the flexibility and scalability needed for modern research workflows. We've got some exciting science lined up over the next two days: 🎤 Today, Dr. Emilie Bureau (GSK) will present new work enabled by the Lumipore® platform at the Tech Theatre. The presentation will highlight photoporation-enabled CRISPR-Cas9 delivery and gene knockout in
- Big news! US Team is expanding quickly. In the past few weeks we were joined by Jordan Vance, Field Application Scientist and Alfred Sloan MBA, Director Business Development USA to support our commercial efforts and to make sure we can serve our customers in the USA. Jordan Vance brings her problem-solving capabilities and expertise in immunology and microbiology to our team. Her research background includes neonatal host response, immune cell characterization, and monoclonal antibody development. During her graduate and
- Greetings from San Francisco! Looking forward to attending the 2026 Fall Senior Executive Conference in Half Moon Bay. Hosted by Analytical, Life Science & Diagnostics Association (ALDA), the conference is a great opportunity to learn from experienced entrepreneurs and executives and to exchange perspectives on company building, commercialization, leadership, and international growth. If you're attending as well, we'd be delighted to connect. Kevin Braeckmans Philip Mathuis #ALDA #OnlyAtALDA #LifeSciences #Biotech
- One week to go until ELRIG Drug Discovery 2026 in London! We're excited to announce that Dr. Emilie Bureau from GSK will be presenting new work on CRISPR-Cas9 gene editing enabled by the Lumipore® intracellular delivery platform. The presentation will explore photoporation for CRISPR-Cas9 RNP delivery and gene knockout in adherent cancer cell models, while maintaining cells in standard assay plates. It will also demonstrate how spatially selective gene editing can be achieved by restricting delivery to defined regions within a
- Last week, Maria Fonseca joined #BostonBiotechWeek and #RESI in Boston on behalf of Obulytix, connecting with investors, biotech entrepreneurs, researchers, and industry leaders from across the life sciences ecosystem. A particular highlight was sharing the experience with the Belgian biotech delegation and exchanging perspectives on the challenges and opportunities of translating innovation from bench to patient in our local ecosystem. At RESI, organized by Life Science Nation, we gained valuable insights into US and
Alumni
Kevin BraeckmansCo-founder and CSO/CTO→Full Professor at Ghent University
Something wrong or missing? Send an update. Fixed within 24 hours.